• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,388.01 -228.39
( -0.29%)
Global Indices
Nasdaq
52,524.20 -133.81
(-0.25%)
Dow Jones
7,536.77 -59.62
(-0.78%)
Hang Seng
67,217.35 -1,340.38
(-1.96%)
Nikkei 225
10,494.06 -3.23
(-0.03%)
Forex
USD-INR
95.45 -0.01
(-0.01%)
EUR-INR
109.10 0.17
(0.15%)
GBP-INR
127.94 0.35
(0.28%)
JPY-INR
0.59 0.00
(0.03%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
423.3622252
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
33.49
115263.37
EPS(TTM)
Face Value()
Div & Yield %
42.61
2
0.91
 

SPV Global Trading reports consolidated net loss of Rs 59.45 crore in the March 2026 quarter
May 30,2026
Net loss of SPV Global Trading reported to Rs 59.45 crore in the quarter ended March 2026 as against net profit of Rs 6.86 crore during the previous quarter ended March 2025. Sales rose 10.93% to Rs 233.59 crore in the quarter ended March 2026 as against Rs 210.57 crore during the previous quarter ended March 2025.

For the full year,net profit rose 803.43% to Rs 131.54 crore in the year ended March 2026 as against Rs 14.56 crore during the previous year ended March 2025. Sales rose 8.67% to Rs 988.90 crore in the year ended March 2026 as against Rs 910.00 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales233.59210.57 11 988.90910.00 9
OPM %-0.519.37 -7.016.63 -
PBDT-24.4115.34 PL 34.1545.06 -24
PBT-26.0913.44 PL 26.5638.24 -31
NP-59.456.86 PL 131.5414.56 803